XTL BIOPHARMACEUTICALS LTD. Acquisitiondate Fair Value Of Total Consideration Transferred
XTL BIOPHARMACEUTICALS LTD. (XTLB) had Acquisitiondate Fair Value Of Total Consideration Transferred of $404.00 thousand as of 2025-03-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes
ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred · last filed 2025-04-30
- 2025-03-31: Acquisitiondate Fair Value Of Total Consideration Transferred $404.00K.
| Period end | Acquisitiondate Fair Value Of Total Consideration Transferred |
|---|---|
| 2025-03-31 | $404.00K 20-F · filed 2025-04-30 |